Belgian investor Gimv has invested €30m of growth capital in Swiss medical device company Spineart.
The proceeds will be used for product development, to improve the company's sales and for further expansion in Europe and the US. The deal marks Gimv's fourth investment in the healthcare space this...
Catch up on essential features from this past week with our round-up of industry analysis
GP acquired a majority stake in French ingredients producer Solina in 2015
Delisting after three years values the equity of Moleskine at €506m
VC acquired a majority stake in the group in 2012 alongside Calliode partners